Cutaneous extranodal natural killer/T-cell lymphoma: A comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site - 14/05/14
Abstract |
Background |
Differences in survival outcomes and prognostic factors of cutaneous extranodal natural killer/T-cell lymphoma (ENKTL) depending on primary tumor site are currently unknown.
Objective |
We sought to analyze the clinicopathological features and survival outcomes of cutaneous ENKTL according to primary tumor site.
Methods |
In all, 45 patients with cutaneous ENKTL were classified with: (1) primary cutaneous ENKTL, or (2) nasal ENKTL with cutaneous involvement. Clinicopathologic features, survival outcomes, and prognostic factors were analyzed using patient's medical records. Survival outcomes were analyzed using the Kaplan-Meier method and compared using the log rank test. The Student t test, Fisher exact test, and linear by linear association test were used to analyze clinicopathologic differences between groups.
Results |
Clinical manifestations of cutaneous ENKTL included solitary or multiple subcutaneous nodules and cellulitis or abscess-like lesions. Primary cutaneous ENKTL demonstrated a less aggressive clinical course and better survival outcomes. The extent of cutaneous lesions demonstrated a significant effect on the prognosis of primary cutaneous ENKTL, but not on nasal ENKTL with cutaneous involvement. The presence of nasal lesions in primary cutaneous ENKTL was associated with poor prognosis.
Limitations |
This study used a retrospective design and included a small sample size.
Conclusion |
Although the clinicopathological features were similar regardless of subgroup, survival outcomes and prognostic factors differed depending on the primary tumor site of cutaneous ENKTL.
Le texte complet de cet article est disponible en PDF.Key words : cutaneous lesion, extranodal natural killer/T-cell lymphoma, prognostic factor, skin, survival outcome, tumor site
Abbreviations used : CI, EBV, ENKTL, IPI, LDH, OS, PFS
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
Vol 70 - N° 6
P. 1002-1009 - juin 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?